Intervention not reportedSerious adverse events · people with cancer pain1 finding from 1 reviewOral paracetamol (acetaminophen) for cancer pain 2017 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 93 participantsVery low
Paracetamol 500 mg to 650 mg vs placeboSerious adverse events · adults with episodic tension‐type headache1 finding from 1 reviewParacetamol (acetaminophen) for acute treatment of episodic tension‐type headache in adults 2016 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedVery low
Paracetamol 1000 mg vs placeboSerious adverse events · adults with episodic tension‐type headache1 finding from 1 reviewParacetamol (acetaminophen) for acute treatment of episodic tension‐type headache in adults 2016 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedModerate
Paracetamol alone, paracetamol plus codeine, or paracetamol plus dihydrocodeine vs placeboSerious adverse events · adults with chronic neuropathic pain1 finding from 1 reviewParacetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults 2016 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedVery low
Intervention not reportedSerious adverse events · Adults with cancer pain1 finding from 1 reviewCodeine, alone and with paracetamol (acetaminophen), for cancer pain 2014 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedVery low
Oral tramadol vs oral morphineSerious adverse events (death) · people with cancer pain1 finding from 1 reviewTramadol with or without paracetamol (acetaminophen) for cancer pain 2017 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 280 participantsVery low